stoxline Quote Chart Rank Option Currency Glossary
  
Envoy Medical, Inc. (COCH)
0.681  0.001 (0.15%)    05-01 16:00
Open: 0.6733
High: 0.7
Volume: 106,831
  
Pre. Close: 0.68
Low: 0.6732
Market Cap: 14(M)
Technical analysis
2026-05-01 4:34:12 PM
Short term     
Mid term     
Targets 6-month :  0.88 1-year :  1.03
Resists First :  0.75 Second :  0.88
Pivot price 0.68
Supports First :  0.66 Second :  0.6
MAs MA(5) :  0.66 MA(20) :  0.67
MA(100) :  0.69 MA(250) :  1.01
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  62.8 D(3) :  50.6
RSI RSI(14): 51.3
52-week High :  1.9 Low :  0.36
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ COCH ] has closed below upper band by 37.8%. Bollinger Bands are 49.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.7 - 0.7 0.7 - 0.71
Low: 0.67 - 0.67 0.67 - 0.67
Close: 0.69 - 0.7 0.7 - 0.7
Company Description

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.

Headline News

Thu, 30 Apr 2026
Envoy Medical (COCH) Expected to Announce Earnings on Thursday - MarketBeat

Tue, 28 Apr 2026
Envoy study: implanted hearing device used 24 hours a day - Stock Titan

Mon, 27 Apr 2026
Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant - Florida Hospital News and Healthcare Report

Thu, 23 Apr 2026
Envoy Medical shares crater after announcing $4 million direct offering - MSN

Wed, 22 Apr 2026
Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant - TMX Newsfile

Wed, 22 Apr 2026
A fully implanted cochlear implant clears key step in 56-patient study - Stock Titan

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 0 (M)
Shares Float 77 (M)
Held by Insiders 4.578e+007 (%)
Held by Institutions 38.2 (%)
Shares Short 952 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -2.178e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -8 %
Return on Assets (ttm) 260 %
Return on Equity (ttm) -137.4 %
Qtrly Rev. Growth 241000 %
Gross Profit (p.s.) 38.34
Sales Per Share 0
EBITDA (p.s.) -216098
Qtrly Earnings Growth -1.3 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -18 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow -3.48
Stock Dividends
Dividend 0
Forward Dividend 1.17e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android